Protein arginine methyltransferase 5 (PRMT5) activates WNT/β‐catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3
<p></p><div> <p>Protein arginine methyltransferase 5 (PRMT5) activity is dysregulated in many aggressive cancers and its enhanced levels are associated with increased tumour growth and survival. However, the role of PRMT5 in breast cancer remains underexplored. In this study,...
محفوظ في:
| المؤلف الرئيسي: | Harshita Shailesh (14779408) (author) |
|---|---|
| مؤلفون آخرون: | Kodappully S. Siveen (4246150) (author), Saïd Sif (13616740) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Aberrant miRNA expression and protein arginine methyltransferase 5 (PRMT5) in cancer: A review
حسب: Saïd Sif (13616740)
منشور في: (2025) -
Engineering β-catenin-derived peptides for α-catenin binding
حسب: S. M. Nasir Uddin (19198030)
منشور في: (2024) -
Exploring the epigenetic landscape: The role of 5-hydroxymethylcytosine in neurodevelopmental disorders
حسب: Mohamed Adil Shah Khoodoruth (14589828)
منشور في: (2024) -
Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
حسب: Radhakrishnan Vishnubalaji (3563306)
منشور في: (2021) -
Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
حسب: Olfa Khalifa (10914452)
منشور في: (2022)